N/A
N=14
Effects of Added D-fagomine on Glycaemic Responses to Sucrose
Reduction of Post-prandial Glycaemic Response
Bottom Line
View on ClinicalTrials.gov: NCT01811303 ↗Enrolled (actual)
14
Serious AEs
0.0%
Results posted
Jul 2013
Primary outcome: Primary: Postprandial Glycaemic Response Index — 73.28; 83.45 percentage of AUC fagomine/AUC control — p=<0.0001
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- D-fagomine (Other)
- Age
- Adult · 18+ yrs
- Sex
- All
- Sponsor
- Bioglane
- Primary completion
- Mar 2013
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Postprandial Glycaemic Response Index |
73.28; 83.45 | <0.0001 sig |
| SECONDARY Maximum Blood Glucose Concentration (C Max) Over the Baseline |
2.3; 3.6 | — |
Summary
The purpose of this study is to determine whether D-fagomine affects glycaemic responses to sucrose (commercial white sugar)and quantify the response
Eligibility Criteria
Inclusion Criteria
- Male or female (not less than 40% Male)
- Aged 18 - 55 years
- Have a body mass index between 18.5 to 29.99 kg/m2
- Healthy, non-diabetic, no gastric bypass surgery
- Have a fasting plasma glucose (finger-stick) <100 mg/dl (<5.5 mmol/L)
- Willing and able to provide written informed consent
Exclusion Criteria
- Smokers
- Allergic to dairy or soy
Data sourced from ClinicalTrials.gov (NCT01811303). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.